Flagship Ventures Fund IV General Partner LLC 13F Holdings · last filed Q2 2016
Flagship Ventures Fund IV General Partner LLC reported 5 securities worth $584.90M in its SEC 13F filing for Q2 2016 (period ended 2016-06-30). Top holdings: MCRB (62.99%), EDIT (20.67%), SYRS (14.92%). Among its top 25 positions this quarter: 2 new, 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MCRB | SERES THERAPEUTICS INC | $368.4M | 62.99% | 12.7M | Trimmed |
| 2 | EDIT | EDITAS MEDICINE INC | $120.9M | 20.67% | 5.0M | New |
| 3 | SYRS | SYROS PHARMACEUTICALS INC | $87.2M | 14.92% | 4.8M | New |
| 4 | TTOO | T2 BIOSYSTEMS INC | $5.9M | 1.00% | 741,755 | Hold |
| 5 | SESN | ELEVEN BIOTHERAPEUTICS INC | $2.5M | 0.42% | 1.5M | Hold |
Source: SEC Form 13F filings · as of 2016-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR